The FDA has issued an emergency use authorization (EUA) to Everlywell, Inc. for the Everlywell COVID-19 Test Home Collection Kit. Everlywell’s kit, a self-collected nasal swab, is authorized to be used by individuals at home who have been screened using an online questionnaire that is reviewed by a health care provider. This marks the first standalone sample collection kit to be granted a proper EUA by the FDA. The FDA has also authorized two COVID-19 diagnostic tests, performed at specific laboratories, for use with samples collected using the Everlywell COVID-19 Test Home Collection Kit. These tests have been authorized under separate, individual EUAs.
Titled the Guiding Principles on Virtual Care, the proposals were developed by various virtual care companies affiliated with CTA, including Livongo, Doctor on Demand, Validic and 98point6. Reports show that patients with access to their own health data are far more likely to engage with the information in ways that improve the quality of care and their overall healthcare experience. The above principles laid out by the CTA are based on concepts and best practices currently present and developing in the U.S. regarding the provision of virtual care and consumer protection.
Over the past decade, patients have taken a more active role in educating themselves and directly managing their own health. And with more than 80 percent of consumers now researching their healthcare options, new technologies provide consumers new ways to engage in their own healthy living and in managing certain conditions. In other words, technology is empowering consumers to take control of their health. Uber Health, Lyft, Walmart Health, Amazon Care are just a few organizations entering the healthcare space.
This is part one of a two week series of posts from CuriousHumans. The American healthcare system is, to put it mildly, complex. As health systems shift their focus from volume to value, a growing number of physician practices are consolidating and more individual physicians are joining health systems.
As organizations consider implementing new technologies or digital therapeutics within their standard of care, the most undeniable element is that it represents powerful change. The demand for digital clinical workspaces will intensify as the natural productivity and mobility benefits become more integrated into health care delivery strategies.
The cost of the opioid epidemic in the United States has climbed to an estimated $1 trillion since 2001, and costs related to the crisis are increasing at an accelerating rate, according to a study released by Altarum, a not-for-profit health research and consulting institute. The annual cost of the opioid crisis increased from $29.1 billion in 2001 to an estimated $115 billion in 2017.
Recent advancements in consumer directed personal computing technology have led to the generation of biomedically-relevant data streams with potential health applications.